CCM
SGHT icon

Coldstream Capital Management’s Sight Sciences SGHT Stock Holding History

Coldstream Capital Management’s Portfolio SGHT Stock Details SGHT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-260
Closed -$624 – 2965
2025
Q1 		$624 Buy
+260
New +$732 ﹤0.01% 3295

Other funds holding SGHT

KL
KCK Ltd Hamilton, Bermuda $15.1M AUM 30.14% 1-Year Est. Return
LFCM
Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return
GAM
Gotham Asset Management New York $32.7B AUM 27.65% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BGI
B Group Inc Dallas, Texas $135M AUM 80% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
AP
Americana Partners Houston, Texas $3.85B AUM 23.11% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
AMH
Apollo Management Holdings New York $7.6B AUM 23.97% 1-Year Est. Return

Coldstream Capital Management's SGHT Position: Q2 2025 in Review

Coldstream Capital Management sold out of Sight Sciences (SGHT) in Q2 2025, closing a stake of 260 shares — an estimated $624 sold.

Coldstream Capital Management first reported a position in SGHT in Q1 2025 and held it in 1 quarter. The position peaked at $624 in Q1 2025. 79 funds tracked by Wall St. Rank hold SGHT as of Q2 2025.

  • Coldstream Capital Management reported no remaining Sight Sciences position as of Q2 2025 after selling out during the quarter.
  • Coldstream Capital Management sold 260 Sight Sciences shares in Q2 2025, an estimated $624.
  • Coldstream Capital Management first reported a position in Sight Sciences in Q1 2025 and held it in 1 quarter.
  • Coldstream Capital Management's Sight Sciences position peaked at $624 in Q1 2025.
  • 79 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2025.

Based on Coldstream Capital Management's 13F filing for Q2 2025, filed 12 Aug 2025.